Litigation
Novartis Pharmaceuticals Corp. v. Mylan Pharmaceuticals Inc.
Settled; consent judgment/injunction1:19-cv-01118-LPS
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
Patents at issue (1)
Plaintiffs (1)
Defendants (1)
Summary
ANDA suit against Mylan (ANDA No. 208005) asserting the '405 patent; settled with proposed consent judgment and injunction filed 2020-10-26; later dispute over post-CAFC launch led to TRO entered 2022-10-11.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).